News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech

News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech
Spotlight

home
Topic
Sun pharmaceuticals

Sun Pharmaceuticals

Sun Pharma Q2 Net Profit Rises 28 Per cent to Rs 3,040 Crore

Sun Pharma Q2 Net Profit Rises 28 Per cent to Rs 3,040 Crore

BY PTI

Sun Pharma To Acquire Remaining 21.52% Shares Of Taro For Rs 2,892 Crore

Sun Pharma To Acquire Remaining 21.52% Shares Of Taro For Rs 2,892 Crore

BY Press Trust of India

USFDA Pulls Up Sun Pharma For Lapses In Halol Plant

Sun Pharma Q2 Net Up 5% At Rs 2,375 Cr

BY Press Trust of India

Sun Pharma Q3 Profit

Sun Pharma Q3 Profit At Rs 2,166 Crore

BY Press Trust of India

Sun Pharmaceutical Launches Phenobarbital Sodium Injection In US

Sun Pharmaceutical Launches Phenobarbital Sodium Injection In US

BY Press Trust of India

Sun Pharmas Halol Facility Listed Under USFDA Import Alert

Sun Pharma's Halol Facility Listed Under USFDA Import Alert

BY Press Trust of India

Sensex.

Markets Settle With Modest Gains In Highly Volatile Trade

BY Press Trust of India

Advertisement

Sun Pharmaceuticals - A Specialty player

Sun Pharmaceuticals - A Specialty player

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2024 Outlook Publishing India Pvt Ltd.

Copyright © 2024 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.